Extreme and consistent insulin price increases are a critical concern for public health. Learn how key policy reforms will affect the insulin landscape and what to expect in 2024.
The prevalence of chronic pain combined with age-related vulnerability make opioid use disorder (OUD) a serious risk for residents of long-term care facilities. Learn the critical steps to recognize and address OUD and ensure resident safety.
Clinical Advisory: Availability of 3-in-1 COVID-19 and Flu A/B Test — Lucira®
Lucira® by Pfizer is a point of care 3-in-1 COVID-19, flu A, and flu B single-use, multiplex test that has been authorized for emergency use by the FDA in individuals 2 years or older who are suspected of a respiratory viral infection consistent with COVID-19.
This report, published annually by the National Center for Assisted Living (NCAL) to summarize state requirements for assisted living licensure or certification, includes state by state information on recent legislative and regulatory updates, scope of care, limitations of services, staffing and training requirements, and more.
F755 provides guidance to surveyors on pharmacy services, drug processing procedures, pharmacist duties, and drug record maintenance, as integral parts of care for managing residents' complex medication regimens. Learn more about the requirements, what surveyors look for, and how your facility can stay in compliance.
